Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification
- PMID: 39179693
- DOI: 10.1038/s41564-024-01786-8
Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification
Abstract
Severe coronavirus disease 2019 and post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are associated with neurological complications that may be linked to direct infection of the central nervous system (CNS), but the selective pressures ruling neuroinvasion are poorly defined. Here we assessed SARS-CoV-2 evolution in the lung versus CNS of infected mice. Higher levels of viral divergence were observed in the CNS than the lung after intranasal challenge with a high frequency of mutations in the spike furin cleavage site (FCS). Deletion of the FCS significantly attenuated virulence after intranasal challenge, with lower viral titres and decreased morbidity compared with the wild-type virus. Intracranial inoculation of the FCS-deleted virus, however, was sufficient to restore virulence. After intracranial inoculation, both viruses established infection in the lung, but dissemination from the CNS to the lung required the intact FCS. Cumulatively, these data suggest a critical role for the FCS in determining SARS-CoV-2 tropism and compartmentalization.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Update of
-
SARS-CoV-2 Bottlenecks and Tissue-Specific Adaptation in the Central Nervous System.Res Sq [Preprint]. 2023 Sep 11:rs.3.rs-3220157. doi: 10.21203/rs.3.rs-3220157/v1. Res Sq. 2023. Update in: Nat Microbiol. 2024 Sep;9(9):2383-2394. doi: 10.1038/s41564-024-01786-8. PMID: 37790412 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- S10 OD032243/OD/NIH HHS/United States
- R01AI15067/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- U19AI135964/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R21AI163912/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- MS200290/United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP)
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous